Status: Not yet recruiting
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.
Participants needed: 810
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Vertanical GmbHUpdated: Jun 25, 2026
Eligibility criteria
Participants ≥ 18 years of age, all sexes [+2]
Pregnant or breastfeeding female patients [+2]